Clinical Trial Update: RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders

View source ↗

Summary

A clinical trial evaluating the risk of stroke in clopidogrel non-responders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Zealand University Hospital | Conditions: Stroke | Status: TERMINATED